DSpace

DSpace at RU >

Browsing by Author Alffenaar, J.W.C.

Jump to a point in the index:
Or type in a year:
Sort by: In order: Results/Page Authors/Record:
Showing results 1 to 8 of 8
Full TextIssue DateTitleAuthor(s)
2012Plasma concentrations of caspofungin at two different dosage regimens in a patient with hepatic dysfunctionvan der Elst, K.C.; Bruggemann, R.J.M.; Rodgers, M.G.; Alffenaar, J.W.C.
2011Fluoroquinolones, the cornerstone of treatment of drug-resistant tuberculosis: a pharmacokinetic and pharmacodynamic approach.Pranger, A.D.; Alffenaar, J.W.C.; Aarnoutse, R.E.
2011Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experiencePranger, A.D.; Altena, R. van; Aarnoutse, R.E.; Soolingen, D. van; Uges, D.R.A., et al
2011Susceptibility of clinical Mycobacterium tuberculosis isolates to a potentially less toxic derivate of linezolid, PNU-100480.Alffenaar, J.W.C.; Laan, T. van der; Simons, S.O.; Werf, T.S. van der; Kasteele, P.J. van de, et al
2011Limited-sampling strategies for therapeutic drug monitoring of moxifloxacin in patients with tuberculosisPranger, A.D.; Kosterink, J.G.W.; Altena, R. van; Aarnoutse, R.E.; Werf, T.S. van der, et al
2009Pharmacokinetics of moxifloxacin in cerebrospinal fluid and plasma in patients with tuberculous meningitis.Alffenaar, J.W.C.; Altena, R. van; Bokkerink, H.J.; Luijckx, G.J.R.; Soolingen, D. van, et al
2009Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents.Bruggemann, R.J.M.; Alffenaar, J.W.C.; Blijlevens, N.M.A.; Billaud, E.M.; Kosterink, J.G.W., et al
2008Pharmacokinetic drug interactions of azoles.Bruggemann, R.J.M.; Alffenaar, J.W.C.; Blijlevens, N.M.A.; Billaud, E.M.; Kosterink, J.G.W., et al
Showing results 1 to 8 of 8

 

  DSpace Software Copyright © 2002-2011  Duraspace - Feedback